Austria (AT)

Matched-paired analysis of patients treated for invasive mucormycosis: Standard treatment versus posaconazole new formulations (MoveOn) (2019) Salmanton-Garcia J, Seidel D, Köhler P, Mellinghoff SC, Herbrecht R, Klimko N, Racil Z, et al. Journal article Contactless Gas Mixture Measurements Using Distributed and Synchronized Low-Cost Millimeter-Wave FMCW Radar Sensors (2019) Och A, Schrattenecker JO, Schuster S, Holzl PA, Freidl PF, Weigel R Conference contribution Fatigue and depression predict health-related quality of life in patients with pediatric-onset multiple sclerosis (2019) Gravesande KSV, Blaschek A, Calabrese P, Rostasy K, Huppke P, Kessler JJ, Kalbe E, et al. Journal article Electrostatically driven encapsulation of hydrophilic, non-conformational peptide epitopes into liposomes (2019) Suleiman E, Damm D, Batzoni M, Temchura V, Wagner A, Überla K, Vorauer-Uhl K Journal article Symptoms, disease severity and treatment of adults with a new diagnosis of severe aortic stenosis (2019) Frey N, Steeds RP, Rudolph TK, Thambyrajah J, Serra A, Schulz E, Maly J, et al. Journal article Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group (2019) Fuchs M, Goergen H, Kobe C, Kuhnert G, Lohri A, Greil R, Sasse S, et al. Journal article Long-term prognostic utility of computed tomography coronary angiography in older populations (2019) Gnanenthiran SR, Naoum C, Leipsic JA, Achenbach S, Al-Mallah MH, Andreini D, Bax JJ, et al. Journal article Wet-chemical porosification of LTCC substrates: Dissolution mechanism and mechanical properties (2019) Hajian A, Brehl M, Koch T, Zellner C, Schwarz S, Konegger T, de Ligny D, Schmid U Journal article Comparing pore structure models of nanoporous carbons obtained from small angle X-ray scattering and gas adsorption (2019) Prehal C, Grätz S, Krüner B, Thommes M, Borchardt L, Presser V, Paris O Journal article Ixazomib–Thalidomide–Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma (2019) Ludwig H, Poenisch W, Knop S, Egle A, Schreder M, Lechner D, Hajek R, et al. Journal article